IMUX
Immunic, Inc.Company with tickers: IMUX
CIK
1280776
CUSIP
4525EP101
Shares Outstanding
13,621,526
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $33,235,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $25,626,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-33,235,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-32,588,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-1.08 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-1.08 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |